SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Medi-Caps Ltd

BSE: 523144 NSE: MEDICAPS ISIN: INE442D01010
  |   Sector:  Chemicals & Fertilizers   |   Industry:  Chemicals

Snapshot

Q.1 Which industry/sub-sector does Medi-Caps Ltd belong to?
Medi-Caps Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.
Q.2 Is Medi-Caps Ltd a good quality company?
Medi-Caps Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Medi-Caps Ltd undervalued or overvalued?
Medi-Caps Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Medi-Caps Ltd a good buy now?
Medi-Caps Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Medi-Caps Ltd?
Medi-Caps Ltd revenue growth is -66.3% for FY-2025 , which is below its 5 year CAGR of -26% , indicating slower growth.
Q.2 Gross Profit margin of Medi-Caps Ltd?
Medi-Caps Ltd Gross profit margin which is the profit after deduction of direct costs, is 18.4% for FY-2025 , which is in line with its 5 year median of 18.4% , indicating stable margins.
Q.3 Operating Profit Margin of Medi-Caps Ltd?
Medi-Caps Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -4.85% for FY-2025 , which is below its 5 year median of 0% indicating decreasing margins.
Q.4 Net Profit Margin of Medi-Caps Ltd?
Medi-Caps Ltd Net Profit Margin is 22.97% for FY-2025 , is in line with with its 5 year median of 22.97%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 18.4 18.4
Operating Profit Margin -4.85 -
Net Profit Margin 22.97 22.97
Q.5 Return on Asset of Medi-Caps Ltd?
Medi-Caps Ltd Return on Asset is 0.82%, which is above its 5 year historical median of 0.42%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Medi-Caps Ltd?
Medi-Caps Ltd Return on equity is 0.83% for FY-2025 , which is above its historical median of 0.42%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Medi-Caps Ltd?
Medi-Caps Ltd Return on capital employed is 0.43% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Medi-Caps Ltd?
Medi-Caps Ltd Cash conversion cycle is 628 days, above its historical median of 176 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.04 -
ROE 0.83 0.42
ROCE 0.43 0.42
Cash Conversion Cycle 628 days 176 days
Q.9 Debt to Equity ratio of Medi-Caps Ltd?
Medi-Caps Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.13 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Medi-Caps Ltd?
Medi-Caps Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Medi-Caps Ltd?
Promoters hold 51.36% of the Medi-Caps Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Medi-Caps Ltd vs industry peers?
Medi-Caps Ltd revenue CAGR is -26.01% , compared to the industry median CAGR of 7.7% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 2.4 202
Gross Profit 0.5 23.6
Operating Profit -0.1 24
Net Profit 0.6 12
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.04 0.93
ROE 0.83 10.18
ROCE 0.43 13.07
Cash Conversion Cycle (days) 628.27 62

Valuation & price assessment

Q.1 Stock return of Medi-Caps Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 2.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 2.8% -5% -7.9% -32.2%
Q.3 Valuation ratios of Medi-Caps Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 43.84 0.00 41.15
Price to Book 0.57 0.42 2.38
Price to Sales 14.5 4.01 1.93
EV to EBITDA 48.29 0.00 13.71

Check more companies

1. Navin Fluorine Intl
2. Godrej Industries
3. Deepak Nitrite
4. Atul
5. Tata Chemicals
6. BASF India
7. Aarti Inds
8. Aether Industries
9. Deepak Fert & Petro
10. Fine Organic Inds.
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×